Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 3Phase 3 2Phase 4 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Mouth Neoplasms 1

Interventions

Cisplatin 17Radiotherapy 8pembrolizumab 7Radiotherapy, Intensity-Modulated 7Fluorouracil 7Magnetic Resonance Spectroscopy 6Docetaxel 6Platinum 5Gemcitabine 51,2-diaminocyclohexaneplatinum II citrate 5Paclitaxel 4Specimen Handling 3Radiation 3Drug Therapy 3Cetuximab 3Carboplatin 3(225)Ac-DOTA-c(RGDyK) 3atezolizumab 2Iodine-123 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Disulfides 2Biopsy 2trametinib 1toripalimab 1ponatinib 1pertuzumab 1nimotuzumab 1fosbretabulin 1fluorocholine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Neck Dissection × Head & Neck × Clear all
NCT04333537 2026-05-04

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

NRG Oncology

Phase 2/3 Recruiting
686 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡